Cargando…

Ten-Year Outcomes of Intravitreal Bevacizumab for Myopic Choroidal Neovascularization: Analysis of Prognostic Factors

The current standard treatment of myopic choroidal neovascularisation (mCNV) is intravitreal injection of VEGF antagonists. This study was proposed to assess efficacy and safety of intravitreal bevacizumab (IVB) for the treatment of mCNV across a 10-year follow-up. Thirty eyes of thirty patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mallone, Fabiana, Giustolisi, Rosalia, Franzone, Federica, Marenco, Marco, Plateroti, Rocco, Nebbioso, Marcella, Lambiase, Alessandro, Gharbiya, Magda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541117/ https://www.ncbi.nlm.nih.gov/pubmed/34681267 http://dx.doi.org/10.3390/ph14101042

Ejemplares similares

Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
por: Wang, Jia-Kang, et al.
Publicado: (2018)

Combined photodynamic therapy and intravitreal bevacizumab as treatment for nonresponsive myopic choroidal neovascularization
por: Chhablani, Jay Kumar
Publicado: (2010)

Analysis of the Pathogenic Factors and Management of Dry Eye in Ocular Surface Disorders
por: Nebbioso, Marcella, et al.
Publicado: (2017)

Single intravitreal ranibizumab for myopic choroidal neovascularization
por: Nor-Masniwati, Saidin, et al.
Publicado: (2011)

Result of intravitreal aflibercept injection for myopic choroidal neovascularization
por: Chen, Shih-Lin, et al.
Publicado: (2021)

Self-sealing posterior scleral perforation in airgun ocular trauma, surgical tip: a case report
por: Mallone, Fabiana, et al.
Publicado: (2020)

Intravitreal Bevacizumab for Management of Choroidal Osteoma without Choroidal Neovascularization
por: Najafabadi, Farhad Fazel, et al.
Publicado: (2015)

Only first intravitreal bevacizumab injection achieves statistically significant visual improvement in naïve myopic choroidal neovascularization
por: Milani, Paolo, et al.
Publicado: (2012)

Choroideremia associated with choroidal neovascularization treated with intravitreal bevacizumab
por: Palejwala, Neal V, et al.
Publicado: (2014)

Choroidal osteoma with choroidal neovascular membrane: Successful treatment with intravitreal bevacizumab
por: Pandey, Neeraj, et al.
Publicado: (2010)

Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
por: Karagiannis, Dimitrios, et al.
Publicado: (2017)

Understanding Vernal Keratoconjunctivitis: Beyond Allergic Mechanisms
por: Sacchetti, Marta, et al.
Publicado: (2021)

Long-term success of intravitreal bevacizumab for choroidal neovascularization associated with choroidal osteoma
por: Kubota-Taniai, Mariko, et al.
Publicado: (2011)

Successful management of choroidal neovascular membrane secondary to choroidal osteoma with intravitreal bevacizumab
por: Takkar, Brijesh, et al.
Publicado: (2017)

Intravitreal Bevacizumab as a Primary Treatment for Idiopathic Choroidal Neovascularization
por: Cheema, Rizwan A., et al.
Publicado: (2011)

Intravitreal bevacizumab in choroidal neovascularization associated with Best's vitelliform dystrophy
por: Mandal, Subrata, et al.
Publicado: (2011)

Intravitreal bevacizumab (Avastin) in choroidal neovascular membrane in angioid streaks
por: Sachdev, Nishant, et al.
Publicado: (2007)

Intravitreal bevacizumab for parafoveal telangiectasia-associated choroidal neovascular membrane
por: Shanmugam, Mahesh P, et al.
Publicado: (2007)

Intravitreal bevacizumab for treatment of choroidal neovascularization associated with osteogenesis imperfecta
por: Rishi, Pukhraj, et al.
Publicado: (2012)

Visual and Anatomical Outcomes of Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration
por: Gharbiya, Magda, et al.
Publicado: (2014)

Long-term outcomes of intravitreal injection of bevacizumab for choroidal neovascularization associated with choroidal osteoma
por: Yoshikawa, Tadanobu, et al.
Publicado: (2015)

Macular Ganglion Cell Layer Thickness after Macula-Off Rhegmatogenous Retinal Detachment Repair: Scleral Buckling versus Pars Plana Vitrectomy
por: Gharbiya, Magda, et al.
Publicado: (2020)

Intravitreal bevacizumab for choroidal neovascular membrane associated with Best's vitelliform dystrophy
por: Rishi, Ekta, et al.
Publicado: (2010)

Intravitreal Bevacizumab for Choroidal Neovascular Membrane in Macular Telangiectasia Type 2
por: Gonzalez Martinez, Orlando G, et al.
Publicado: (2023)

X-linked dominant RPGR gene mutation in a familial Coats angiomatosis
por: Nebbioso, Marcella, et al.
Publicado: (2021)

Understanding Drivers of Ocular Fibrosis: Current and Future Therapeutic Perspectives
por: Mallone, Fabiana, et al.
Publicado: (2021)

Insights into Novel Choroidal and Retinal Clinical Signs in Neurofibromatosis Type 1
por: Mallone, Fabiana, et al.
Publicado: (2023)

Photodynamic Therapy Combined with Intravitreal Bevacizumab in a Patient with Choroidal Neovascularization Secondary to Choroidal Osteoma
por: Jang, Jung Hyun, et al.
Publicado: (2012)

Comparison of intravitreal bevacizumab and ranibizumab used for myopic choroidal neovascularization: A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials
por: Hu, Qiuming, et al.
Publicado: (2019)

Intravitreal bevacizumab for subfoveal choroidal neovascularization complicating active central serous chorioretinopathy
por: Mandal, Subrata, et al.
Publicado: (2011)

Pneumatic displacement and intravitreal bevacizumab for management of submacular hemorrhage in choroidal neovascular membrane
por: Agarwal, Manisha, et al.
Publicado: (2010)

Skin rash associated with intravitreal bevacizumab in a patient with macular choroidal neovascularization
por: Ladas, Ioannis D, et al.
Publicado: (2009)

Intravitreal Bevacizumab for Choroidal Neovascularization Secondary to Non-Age-Related Macular Degeneration
por: Salehipour, Masoud, et al.
Publicado: (2010)

A Case of Intravitreal Bevacizumab Injection for the Treatment of Choroidal Neovascularization in Angioid Streaks
por: Lee, Ji Woong, et al.
Publicado: (2011)

Intravitreal Bevacizumab for Choroidal Neovascularization Associated with Angioid Streaks: Long-term Results
por: Lekha, T., et al.
Publicado: (2017)

Recent Advances and Disputes About Curcumin in Retinal Diseases
por: Nebbioso, Marcella, et al.
Publicado: (2021)

Optical Coherence Tomography Angiography Evolution of Choroidal Neovascular Membrane in Choroidal Rupture Managed by Intravitreal Bevacizumab
por: Lorusso, Massimo, et al.
Publicado: (2019)

Intravitreal bevacizumab for iatrogenic choroidal neovascular membrane following vitreoretinal surgery for retinal detachment
por: Appanraj, Ramya, et al.
Publicado: (2020)

Intravitreal Bevacizumab for the Treatment of Choroidal Neovascularization after Eyeball Perforation during Retrobulbar Anesthesia
por: Kim, Kyung Won, et al.
Publicado: (2021)

A systematic review and meta-analysis comparing intravitreal ranibizumab with bevacizumab for the treatment of myopic choroidal neovascularisation
por: Loutfi, M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_kkiao1rj8d348pr3gkc41vlr29